Latest News and Press Releases

Boston, June 03, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Global Epigenetics Markets” is projected to grow from $4.8 billion in 2024 to $8.5 billion by the end...

$NSTM: NovelStem Announces Material Developments and Strategic Repositioning of the Company.

Purchase is subject to bankruptcy court and regulatory approvals Regeneron will prioritize the privacy, security and ethical use of 23andMe’s customer data; stands ready to work with independent,...

Tec de Monterrey and UT Austin launch OriGen Health to advance precision medicine and Latino health using AI, genetics, and Latin America’s largest biobank

Drs. David Sinclair & Jeffrey Lieberman to explore the latest advances in longevity science and emerging new model for living better, longer at SXSW 2025

Boston, Feb. 27, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the demand for Direct-to-Consumer Genetic Testing: Global Markets and Technologies is expected to grow from...

NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- February is Cancer Prevention Month, and the perfect opportunity to highlight the importance of genetic testing in understanding cancer risk factors....

PALO ALTO, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Digbi Health, a pioneer in Precision Biology, is advancing obesity management with groundbreaking enhancements to GLP-Compass (™), its...

The Truveta collaboration will extend Regeneron Genetics Center’s® (RGCTM) world-leading DNA sequence-linked healthcare database (now including almost three million de-identified patient volunteers)...

Myriad Genetics announced Prolaris prostate cancer prognostic test is classified by the NCCN as an advanced tool in the fight against prostate cancer.